TW200724537A - Pyrimidine derivatives for treatment of hyperproliferative disorders - Google Patents
Pyrimidine derivatives for treatment of hyperproliferative disordersInfo
- Publication number
- TW200724537A TW200724537A TW095107853A TW95107853A TW200724537A TW 200724537 A TW200724537 A TW 200724537A TW 095107853 A TW095107853 A TW 095107853A TW 95107853 A TW95107853 A TW 95107853A TW 200724537 A TW200724537 A TW 200724537A
- Authority
- TW
- Taiwan
- Prior art keywords
- treatment
- pyrimidine derivatives
- hyperproliferative disorders
- compounds
- cancer
- Prior art date
Links
- 230000003463 hyperproliferative effect Effects 0.000 title abstract 2
- 229940083082 pyrimidine derivative acting on arteriolar smooth muscle Drugs 0.000 title abstract 2
- 150000003230 pyrimidines Chemical class 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66056105P | 2005-03-10 | 2005-03-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200724537A true TW200724537A (en) | 2007-07-01 |
Family
ID=36624969
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW095107853A TW200724537A (en) | 2005-03-10 | 2006-03-09 | Pyrimidine derivatives for treatment of hyperproliferative disorders |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20110098301A1 (zh) |
| EP (1) | EP1858882A1 (zh) |
| JP (1) | JP2008533042A (zh) |
| KR (1) | KR20080004488A (zh) |
| CN (1) | CN101151258A (zh) |
| AR (1) | AR053554A1 (zh) |
| AU (1) | AU2006223199A1 (zh) |
| BR (1) | BRPI0609022A2 (zh) |
| CA (1) | CA2601257A1 (zh) |
| CR (1) | CR9347A (zh) |
| DO (1) | DOP2006000061A (zh) |
| EA (1) | EA200701930A1 (zh) |
| GT (1) | GT200600105A (zh) |
| IL (1) | IL185498A0 (zh) |
| MA (1) | MA29377B1 (zh) |
| MX (1) | MX2007010102A (zh) |
| NO (1) | NO20074964L (zh) |
| PE (1) | PE20061067A1 (zh) |
| TN (1) | TNSN07322A1 (zh) |
| TW (1) | TW200724537A (zh) |
| UY (1) | UY29414A1 (zh) |
| WO (1) | WO2006099231A1 (zh) |
| ZA (1) | ZA200708591B (zh) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009530386A (ja) * | 2006-03-20 | 2009-08-27 | バイエル・ヘルスケア・エルエルシー | パクリタキセル組み合わせ物 |
| EP2173722B1 (en) * | 2007-07-26 | 2012-08-29 | Novartis AG | Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions |
| DE102008015033A1 (de) | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung |
| DE102008015032A1 (de) | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituierte Pyrazolamide und ihre Verwendung |
| DE102008062878A1 (de) | 2008-12-17 | 2010-06-24 | Aicuris Gmbh & Co. Kg | Substituierte Furancarboxamide und ihre Verwendung |
| DE102008062863A1 (de) | 2008-12-17 | 2010-06-24 | Aicuris Gmbh & Co. Kg | Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung |
| AU2011310532B2 (en) | 2010-10-01 | 2016-01-14 | Bayer Intellectual Property Gmbh | Substituted N-(2-arylamino)aryl sulfonamide-containing combinations |
| EA201390917A1 (ru) | 2010-12-21 | 2013-12-30 | Новартис Аг | Дигетероарильные соединения в качестве ингибиторов vps34 |
| PE20140502A1 (es) | 2011-04-22 | 2014-05-02 | Signal Pharm Llc | Pirimidinas sustituidas de diaminocarboxamida y diaminocarbonitrilo, composiciones de las mismas y metodos de tratamiento con las mismas |
| KR20220143164A (ko) | 2012-11-21 | 2022-10-24 | 피티씨 테라퓨틱스, 인크. | 치환된 리버스 피리미딘 ｂｍｉ-1 저해제 |
| CN103408573B (zh) * | 2013-07-12 | 2015-12-23 | 上海工程技术大学 | 硼酸衍生物及其制备方法和应用 |
| CA2922657C (en) | 2013-08-30 | 2022-04-12 | Ptc Therapeutics, Inc. | Substituted pyrimidine bmi-1 inhibitors |
| US10584115B2 (en) | 2013-11-21 | 2020-03-10 | Ptc Therapeutics, Inc. | Substituted pyridine and pyrazine BMI-1 inhibitors |
| NZ715903A (en) | 2014-01-30 | 2017-06-30 | Signal Pharm Llc | Solid forms of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use |
| US9638690B2 (en) | 2014-11-07 | 2017-05-02 | The University Of British Columbia | Compounds and compositions for use as alkylating agent sensors and methods of use thereof |
| CA2975260C (en) | 2015-01-29 | 2024-05-21 | Signal Pharmaceuticals Llc | Isotopologues of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide |
| MX2018001004A (es) | 2015-07-24 | 2018-06-07 | Celgene Corp | Metodos de sintesis de clorhidrato de (1r,2r,5r)-5-amino-2-metilci clohexanol e intermedios utiles en este. |
| TWI609028B (zh) | 2016-05-06 | 2017-12-21 | 財團法人工業技術研究院 | 共聚物與含其之樹脂組合物、封裝膜及封裝結構 |
| BR112021002630A2 (pt) | 2018-08-17 | 2021-05-11 | Ptc Therapeutics, Inc. | método para tratar câncer pancreático |
| CN111518078B (zh) * | 2020-05-30 | 2021-02-26 | 南方医科大学 | 一种含氨基吡啶的嘧啶类化合物及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3089480B2 (ja) * | 1990-09-20 | 2000-09-18 | ソニー株式会社 | フリットシール装置 |
| US6943172B2 (en) * | 2002-01-23 | 2005-09-13 | Bayer Pharmaceuticals Corporation | Rho-kinase inhibitors |
| US6924290B2 (en) * | 2002-01-23 | 2005-08-02 | Bayer Pharmaceuticals Corporation | Rho-kinase inhibitors |
| WO2005035507A2 (en) * | 2003-10-10 | 2005-04-21 | Bayer Pharmaceuticals Corporation | 4-aminopyrimidine derivatives for treatment of hyperproliferative disorders |
-
2006
- 2006-03-09 CA CA002601257A patent/CA2601257A1/en not_active Abandoned
- 2006-03-09 PE PE2006000271A patent/PE20061067A1/es not_active Application Discontinuation
- 2006-03-09 AU AU2006223199A patent/AU2006223199A1/en not_active Abandoned
- 2006-03-09 EP EP06737910A patent/EP1858882A1/en not_active Withdrawn
- 2006-03-09 DO DO2006000061A patent/DOP2006000061A/es unknown
- 2006-03-09 UY UY29414A patent/UY29414A1/es not_active Application Discontinuation
- 2006-03-09 KR KR1020077023009A patent/KR20080004488A/ko not_active Withdrawn
- 2006-03-09 CN CNA2006800077914A patent/CN101151258A/zh active Pending
- 2006-03-09 EA EA200701930A patent/EA200701930A1/ru unknown
- 2006-03-09 BR BRPI0609022-2A patent/BRPI0609022A2/pt not_active IP Right Cessation
- 2006-03-09 TW TW095107853A patent/TW200724537A/zh unknown
- 2006-03-09 WO PCT/US2006/008779 patent/WO2006099231A1/en not_active Ceased
- 2006-03-09 US US11/886,132 patent/US20110098301A1/en not_active Abandoned
- 2006-03-09 MX MX2007010102A patent/MX2007010102A/es not_active Application Discontinuation
- 2006-03-09 GT GT200600105A patent/GT200600105A/es unknown
- 2006-03-09 JP JP2008501008A patent/JP2008533042A/ja active Pending
- 2006-03-10 AR ARP060100919A patent/AR053554A1/es not_active Application Discontinuation
-
2007
- 2007-08-22 TN TNP2007000322A patent/TNSN07322A1/en unknown
- 2007-08-23 IL IL185498A patent/IL185498A0/en unknown
- 2007-08-28 CR CR9347A patent/CR9347A/es not_active Application Discontinuation
- 2007-10-02 MA MA30266A patent/MA29377B1/fr unknown
- 2007-10-02 NO NO20074964A patent/NO20074964L/no not_active Application Discontinuation
- 2007-10-09 ZA ZA200708591A patent/ZA200708591B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20110098301A1 (en) | 2011-04-28 |
| JP2008533042A (ja) | 2008-08-21 |
| CN101151258A (zh) | 2008-03-26 |
| NO20074964L (no) | 2007-12-06 |
| DOP2006000061A (es) | 2006-09-30 |
| KR20080004488A (ko) | 2008-01-09 |
| CA2601257A1 (en) | 2006-09-21 |
| MX2007010102A (es) | 2007-10-12 |
| EP1858882A1 (en) | 2007-11-28 |
| UY29414A1 (es) | 2006-10-02 |
| PE20061067A1 (es) | 2006-11-30 |
| IL185498A0 (en) | 2008-01-06 |
| AU2006223199A1 (en) | 2006-09-21 |
| CR9347A (es) | 2007-12-17 |
| BRPI0609022A2 (pt) | 2010-01-12 |
| MA29377B1 (fr) | 2008-04-01 |
| TNSN07322A1 (en) | 2008-12-31 |
| EA200701930A1 (ru) | 2008-02-28 |
| GT200600105A (es) | 2007-02-14 |
| AR053554A1 (es) | 2007-05-09 |
| ZA200708591B (en) | 2009-01-28 |
| WO2006099231A1 (en) | 2006-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TNSN07322A1 (en) | Pyrimidine derivatives for treatment of hyperproliferative disorders | |
| IL260127B (en) | mek inhibitors and methods of using them | |
| IL184872A0 (en) | Pyrazole derivatives, pharmaceutical compositions containing them and use thereof in the manufacture of medicaments for treatment and prevention of cancers | |
| IL185063A0 (en) | Pyrazole derivatives, pharmaceutical compositions containing them and use thereof in the manufacture of medicaments for treatment and prevention of cancers | |
| WO2005110994A8 (en) | Substituted pyrazolyl urea derivatives useful in the treatment of cancer | |
| MX2011012337A (es) | Nuevos derivados de pirimidina y su uso en el tratamiento de cancer y de otras enfermedades. | |
| MX2009006704A (es) | Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa. | |
| MX2009006706A (es) | Compuestos heterociclicos biciclicos como inhibidores del receptor del factor de crecimiento de fibroblastos. | |
| WO2006086562A3 (en) | Phenylazetidinone derivatives | |
| IL180677A0 (en) | Compounds, compositions and methods for treatment of hyperproliferative diseases, such as cancer | |
| PL1951729T3 (pl) | Pochodne pirymidyny połączone przez atom tlenu | |
| MY149960A (en) | 4-(phenylamino)-6-oxo-1,6-dihydropyridazine-3-carboxamide derivatives as mek inhibitors for the treatment of hyperproliferative diseases | |
| TW200800963A (en) | Chemical compounds | |
| MY149512A (en) | Pyrazolylaminopyridine derivatives useful as kinase inhibitors | |
| MX2009010059A (es) | Derivados de quinolina para el tratamiento de enfermedades inflamatorias. | |
| IL184898A0 (en) | Pyrrolopyrimidine derivatives and pharmaceutical compositions containing the same | |
| UA98961C2 (uk) | Похідні піразинону та їх застосування у лікуванні легеневих захворювань | |
| TNSN08370A1 (en) | Tetrahydropyridothienopyrimidine compounds and methods of use thereof | |
| TW200606162A (en) | Pyrazolopyridine derivatives | |
| WO2008013987A3 (en) | N-alkyl substituted piperazinylmethylquinazolinones and azepanylmethylquinazolinones | |
| MX2012013274A (es) | Novedosos derivados de la pirimidina. | |
| EA201001196A1 (ru) | Соединения 4-пиридинона и их применение для лечения рака | |
| WO2007076085A3 (en) | Fused pyrimidones and thiopyrimidones, and uses thereof | |
| MXPA06009475A (es) | Derivados de quinazolina y usos terapeuticos de los mismos. | |
| TW200738659A (en) | Novel compounds |